NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Theratechnologies Inc (NASDAQ: THTX)
THTX Technical Analysis
5
As on 9th Jun 2023 THTX STOCK Price closed @ 0.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.43 & Strong Sell for SHORT-TERM with Stoploss of 2.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
THTXSTOCK Price
Open | 0.96 | Change | Price | % |
High | 0.96 | 1 Day | -0.04 | -4.08 |
Low | 0.90 | 1 Week | -0.01 | -1.05 |
Close | 0.94 | 1 Month | -0.02 | -2.08 |
Volume | 47900 | 1 Year | -2.22 | -70.25 |
52 Week High 3.24 | 52 Week Low 0.72 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
THTX Daily Charts |
THTX Intraday Charts |
Whats New @ Bazaartrend |
THTX Free Analysis |
|
THTX Important Levels Intraday
RESISTANCE | 1.06 |
RESISTANCE | 1.02 |
RESISTANCE | 1.00 |
RESISTANCE | 0.97 |
SUPPORT | 0.91 |
SUPPORT | 0.88 |
SUPPORT | 0.86 |
SUPPORT | 0.82 |
THTX Forecast May 2024
4th UP Forecast | 1.88 |
3rd UP Forecast | 1.58 |
2nd UP Forecast | 1.39 |
1st UP Forecast | 1.21 |
1st DOWN Forecast | 0.67 |
2nd DOWN Forecast | 0.49 |
3rd DOWN Forecast | 0.3 |
4th DOWN Forecast | 0 |
THTX Weekly Forecast
4th UP Forecast | 1.46 |
3rd UP Forecast | 1.29 |
2nd UP Forecast | 1.19 |
1st UP Forecast | 1.09 |
1st DOWN Forecast | 0.79 |
2nd DOWN Forecast | 0.69 |
3rd DOWN Forecast | 0.59 |
4th DOWN Forecast | 0.42 |
THTX Forecast2024
4th UP Forecast | 5.87 |
3rd UP Forecast | 4.29 |
2nd UP Forecast | 3.31 |
1st UP Forecast | 2.34 |
1st DOWN Forecast | -0.46 |
2nd DOWN Forecast | -1.43 |
3rd DOWN Forecast | -2.41 |
4th DOWN Forecast | -3.99 |
Theratechnologies Inc ( NASDAQ USA Symbol : THTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
THTX Other Details
Segment | EQ | |
Market Capital | 333638528.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
THTX Address
THTX Latest News
THTX Business Profile
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada. Address: 2015 Peel Street, Montreal, QC, Canada, H3A 1T8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service